201 related articles for article (PubMed ID: 34106022)
21. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
[TBL] [Abstract][Full Text] [Related]
22. NUT midline carcinoma of the larynx: an international series and review of the literature.
Hellquist H; French CA; Bishop JA; Coca-Pelaz A; Propst EJ; Paiva Correia A; Ngan BY; Grant R; Cipriani NA; Vokes D; Henrique R; Pardal F; Vizcaino JR; Rinaldo A; Ferlito A
Histopathology; 2017 May; 70(6):861-868. PubMed ID: 27926786
[TBL] [Abstract][Full Text] [Related]
23. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.
Evans AG; French CA; Cameron MJ; Fletcher CD; Jackman DM; Lathan CS; Sholl LM
Am J Surg Pathol; 2012 Aug; 36(8):1222-7. PubMed ID: 22790861
[TBL] [Abstract][Full Text] [Related]
24. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.
Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L
Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291
[TBL] [Abstract][Full Text] [Related]
25. Tumor Mutation Burden and Checkpoint Immunotherapy Markers in NUT Midline Carcinoma.
He M; Chernock R; Zhou S; Gondim M; Dehner LP; Pfeifer JD
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):495-500. PubMed ID: 31180909
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
Chen M; Chen X; Zhang Y; Wang W; Jiang L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
[TBL] [Abstract][Full Text] [Related]
27. Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.
Sholl LM; Nishino M; Pokharel S; Mino-Kenudson M; French CA; Janne PA; Lathan C
J Thorac Oncol; 2015 Jun; 10(6):951-9. PubMed ID: 26001144
[TBL] [Abstract][Full Text] [Related]
28. NUT midline carcinoma.
French CA
Cancer Genet Cytogenet; 2010 Nov; 203(1):16-20. PubMed ID: 20951314
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma.
Xie M; Fu X; Wang W
Cancer Med; 2021 Sep; 10(17):5757-5764. PubMed ID: 34409758
[TBL] [Abstract][Full Text] [Related]
30. Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers.
Hung YP; Chen AL; Taylor MS; Huynh TG; Kem M; Selig MK; Nielsen GP; Lennerz JK; Azzoli CG; Dagogo-Jack I; Kradin RL; Mino-Kenudson M
Histopathology; 2021 May; 78(6):896-904. PubMed ID: 33231320
[TBL] [Abstract][Full Text] [Related]
31. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
[TBL] [Abstract][Full Text] [Related]
32. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
[TBL] [Abstract][Full Text] [Related]
33. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.
Stelow EB; Bellizzi AM; Taneja K; Mills SE; Legallo RD; Kutok JL; Aster JC; French CA
Am J Surg Pathol; 2008 Jun; 32(6):828-34. PubMed ID: 18391746
[TBL] [Abstract][Full Text] [Related]
34. NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum.
Stevens TM; Morlote D; Xiu J; Swensen J; Brandwein-Weber M; Miettinen MM; Gatalica Z; Bridge JA
Mod Pathol; 2019 Jun; 32(6):764-773. PubMed ID: 30723300
[TBL] [Abstract][Full Text] [Related]
35. Nuclear protein in testis midline carcinomas: a lethal and underrecognized entity.
Davis BN; Karabakhtsian RG; Pettigrew AL; Arnold SM; French CA; Brill YM
Arch Pathol Lab Med; 2011 Nov; 135(11):1494-8. PubMed ID: 22032580
[TBL] [Abstract][Full Text] [Related]
36. Ultrastructural features of NUT midline carcinoma.
Wartchow EP; Moore TS; French CA; Mierau GW
Ultrastruct Pathol; 2012 Aug; 36(4):280-4. PubMed ID: 22849529
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review.
Lee T; Cho J; Baek CH; Son YI; Jeong HS; Chung MK; Hong SD; Ahn YC; Oh DR; Noh JM; Park K; Ahn MJ; Kim HJ; Kim YK; Ko YH
Head Neck; 2020 May; 42(5):924-938. PubMed ID: 31903701
[TBL] [Abstract][Full Text] [Related]
38. HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report.
Esteves G; Ferreira J; Afonso R; Martins C; Zagalo C; Félix A
Head Neck Pathol; 2020 Dec; 14(4):1117-1122. PubMed ID: 31989434
[TBL] [Abstract][Full Text] [Related]
39. NUT carcinoma in children and adults: A multicenter retrospective study.
Lemelle L; Pierron G; Fréneaux P; Huybrechts S; Spiegel A; Plantaz D; Julieron M; Dumoucel S; Italiano A; Millot F; Le Tourneau C; Leverger G; Chastagner P; Carton M; Orbach D
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643357
[TBL] [Abstract][Full Text] [Related]
40. Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature.
Wang H; Weiss VL; Hoffman RD; Abel T; Ho RH; Borinstein SC; Mannion K; Bridge JA; Black J; Liang J
Head Neck Pathol; 2021 Mar; 15(1):236-243. PubMed ID: 32077054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]